| NAV | $30.59 | Daily Change | $0.10 | 0.33% |
| Market Price | $30.63 | Daily Change | $0.23 | 0.76% |
Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1
With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to seniors' distinct consumer preferences.
The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.
1WHO, Oct 2022
| Inception Date | 05/09/16 |
| Total Expense Ratio | 0.50% |
| Net Assets | $58.42 million |
| NAV | $30.59 |
| Fact Sheet | View the document |
The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.
The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.
| Ticker | AGNG |
| Bloomberg Index Ticker | ILNGRNT |
| CUSIP | 37954Y772 |
| ISIN | US37954Y7720 |
| Primary Exchange | Nasdaq |
| Shares Outstanding | 1,910,000 |
| Number of Holdings | 83 |
| 30-Day Median Bid-Ask Spread | 0.36% |
| 30-Day SEC Yield | 0.97% |
| Distribution Frequency | Semi-Annually |
| NAV | $30.59 | Daily Change | $0.10 | 0.33% |
| Market Price | $30.63 | Daily Change | $0.23 | 0.76% |
|
As of recent (09/30/24)
As of recent (09/30/24)
|
Fund NAV | Market Price | Index |
|---|---|---|---|
| 1 Year | 26.40% | 27.20% | 26.83% |
| 3 Years | 4.73% | 5.07% | 5.01% |
| 5 Years | 9.83% | 9.72% | 10.10% |
| Since Inception | 10.37% | 10.67% | 10.66% |
| 1 Year | 19.41% | 20.00% | 19.83% |
| 3 Years | 6.05% | 5.99% | 6.35% |
| 5 Years | 7.02% | 6.88% | 7.29% |
| Since Inception | 9.82% | 10.10% | 10.12% |
| Year-to-Date | 15.27% | 15.84% | 15.54% |
| 1 Month | -1.21% | -1.03% | -1.16% |
| 3 Months | 8.95% | 9.14% | 9.11% |
| Since Inception | 128.99% | 134.39% | 134.20% |
| Year-to-Date | 12.31% | 12.73% | 12.69% |
| 1 Month | -0.25% | -0.19% | -0.22% |
| 3 Months | -3.74% | -3.68% | -3.60% |
| Since Inception | 123.12% | 128.11% | 128.41% |
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.
| Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
|---|---|---|---|---|---|---|
| 4.05 | WELL | WELLTOWER INC | BYVYHH4 | 126.59 | 18,681 | 2,364,827.79 |
| 3.82 | BSX | BOSTON SCIENTIFIC CORP | 2113434 | 91.07 | 24,526 | 2,233,582.82 |
| 3.72 | 4519 JP | CHUGAI PHARMA CO | 6196408 | 43.98 | 49,375 | 2,171,571.12 |
| 3.40 | BMY | BRISTOL-MYERS SQUIBB CO | 2126335 | 57.76 | 34,373 | 1,985,384.48 |
| 3.35 | UCB BB | UCB SA | 5596991 | 196.83 | 9,942 | 1,956,927.97 |
| 3.10 | ABBV | ABBVIE INC | B92SR70 | 180.00 | 10,055 | 1,809,900.00 |
| 3.10 | SYK | STRYKER CORP | 2853688 | 370.78 | 4,877 | 1,808,294.06 |
| 3.03 | LLY | ELI LILLY & CO | 2516152 | 795.67 | 2,222 | 1,767,978.74 |
| 2.99 | ALC SW | ALCON INC | BJT1GR5 | 84.88 | 20,565 | 1,745,462.51 |
| 2.86 | MDT | MEDTRONIC PLC | BTN1Y11 | 81.54 | 20,502 | 1,671,733.08 |
| 2.83 | JNJ | JOHNSON & JOHNSON | 2475833 | 145.85 | 11,348 | 1,655,105.80 |
| 2.82 | AMGN | AMGEN INC | 2023607 | 264.49 | 6,238 | 1,649,888.62 |
| 2.75 | AZN | ASTRAZENECA PLC-SPONS ADR | 2989044 | 66.30 | 24,256 | 1,608,172.80 |
| 2.73 | RO SW | ROCHE HOLDING AG-BR | 7108918 | 293.72 | 5,425 | 1,593,445.08 |
| 2.52 | 068270 KS | CELLTRION INC | B0C5YV1 | 133.47 | 11,050 | 1,474,850.67 |
| 2.52 | 4543 JP | TERUMO CORP | 6885074 | 19.29 | 76,199 | 1,469,835.80 |
| 2.38 | EW | EDWARDS LIFESCIENCES CORP | 2567116 | 75.38 | 18,471 | 1,392,343.98 |
| 2.24 | REGN | REGENERON PHARMACEUTICALS | 2730190 | 714.47 | 1,829 | 1,306,765.63 |
| 2.08 | VTR | VENTAS INC | 2927925 | 59.27 | 20,527 | 1,216,635.29 |
| 2.00 | NOVOB DC | NOVO NORDISK A/S-B | BP6KMJ1 | 86.72 | 13,499 | 1,170,621.55 |
| 1.92 | ZBH | ZIMMER BIOMET HO | 2783815 | 107.30 | 10,459 | 1,122,250.70 |
| 1.76 | STMN SW | STRAUMANN HOLDING AG-REG | BQ7ZV06 | 126.82 | 8,126 | 1,030,577.23 |
| 1.70 | SOON SW | SONOVA HOLDING AG-REG | 7156036 | 328.13 | 3,030 | 994,247.65 |
| 1.66 | DXCM | DEXCOM INC | B0796X4 | 80.24 | 12,093 | 970,342.32 |
| 1.61 | PODD | INSULET CORP | B1XGNW4 | 263.23 | 3,570 | 939,731.10 |
| 1.55 | SDZ SW | SANDOZ GROUP AG | BLPLD38 | 41.14 | 21,981 | 904,274.70 |
| 1.54 | 4503 JP | ASTELLAS PHARMA INC | 6985383 | 9.73 | 92,441 | 899,205.23 |
| 1.51 | BGNE | BEIGENE LTD-ADR | BYYWPW6 | 181.62 | 4,866 | 883,762.92 |
| 1.48 | UTHR | UNITED THERAPEUTICS CORP | 2430412 | 360.87 | 2,399 | 865,727.13 |
| 1.36 | INCY | INCYTE CORP | 2471950 | 69.91 | 11,398 | 796,834.18 |
| 1.21 | 3692 HK | HANSOH PHARMACEU | BJYKB72 | 2.34 | 301,843 | 707,279.07 |
| 1.20 | GMAB DC | GENMAB A/S | 4595739 | 206.84 | 3,378 | 698,701.86 |
| 1.18 | DVA | DAVITA INC | 2898087 | 155.06 | 4,453 | 690,482.18 |
| 1.18 | NBIX | NEUROCRINE BIOSC | 2623911 | 136.53 | 5,051 | 689,613.03 |
| 1.16 | FME GR | FRESENIUS MEDICAL CARE AG | 5129074 | 45.26 | 14,924 | 675,452.02 |
| 1.05 | COH AU | COCHLEAR LTD | 6211798 | 184.80 | 3,328 | 615,005.86 |
| 0.94 | SN/ LN | SMITH & NEPHEW PLC | 0922320 | 12.36 | 44,472 | 549,870.11 |
| 0.92 | EXAS | EXACT SCIENCES CORP | 2719951 | 58.11 | 9,228 | 536,239.08 |
| 0.90 | EXEL | EXELIXIS INC | 2576941 | 33.82 | 15,463 | 522,958.66 |
| 0.82 | OHI | OMEGA HEALTHCARE | 2043274 | 38.19 | 12,463 | 475,961.97 |
| 0.80 | PHM SM | PHARMA MAR SA | BMW2GT8 | 83.04 | 5,656 | 469,653.20 |
| 0.72 | TFX | TELEFLEX INC | 2881407 | 177.26 | 2,387 | 423,119.62 |
| 0.71 | DEMANT DC | DEMANT A/S | BZ01RF1 | 36.46 | 11,356 | 414,095.80 |
| 0.66 | ENSG | ENSIGN GROUP INC/THE | B1YWPP8 | 134.72 | 2,867 | 386,242.24 |
| 0.65 | GKOS | GLAUKOS CORP | BYMWL19 | 151.22 | 2,504 | 378,654.88 |
| 0.63 | NVCR | NOVOCURE LTD | BYSS4X4 | 30.97 | 11,862 | 367,366.14 |
| 0.53 | EMBC | EMBECTA CORP | BMXWYR1 | 20.28 | 15,216 | 308,580.48 |
| 0.52 | HALO | HALOZYME THERAPEUTICS INC | 2975098 | 47.54 | 6,433 | 305,824.82 |
| 0.52 | AMP IM | AMPLIFON SPA | B14NJ71 | 26.49 | 11,480 | 304,111.49 |
| 0.49 | MMSI | MERIT MEDICAL SYSTEMS INC | 2580555 | 98.08 | 2,936 | 287,962.88 |
| 0.48 | BPMC | BLUEPRINT MEDICINES CORP | BWY52P3 | 90.46 | 3,101 | 280,516.46 |
| 0.45 | MNKD | MANNKIND CORP | BF081J4 | 6.74 | 38,960 | 262,590.40 |
| 0.43 | YPSN SW | YPSOMED HOLDING AG-REG | B02SWN8 | 366.32 | 691 | 253,127.60 |
| 0.39 | ITGR | INTEGER HOLDINGS CORP | BD06LM7 | 134.75 | 1,694 | 228,266.50 |
| 0.36 | SBRA | SABRA HEALTH CAR | B5NLBP6 | 17.08 | 12,152 | 207,556.16 |
| 0.36 | NHC | NATIONAL HEALTHCARE CORP | 2139731 | 111.29 | 1,865 | 207,555.85 |
| 0.34 | NHI | NATL HEALTH INVESTORS INC | 2626125 | 69.38 | 2,844 | 197,316.72 |
| 0.33 | CSH-U CN | CHARTWELL RETIRE | B8S8C94 | 10.58 | 18,273 | 193,256.84 |
| 0.33 | 8086 JP | NIPRO CORP | 6641599 | 9.33 | 20,328 | 189,727.14 |
| 0.32 | SIA CN | SIENNA SENIOR LIVING INC | BWTYXH4 | 10.90 | 17,266 | 188,129.35 |
| 0.32 | AGIO | AGIOS PHARMACEUTICALS INC | BCBVTX1 | 34.19 | 5,472 | 187,087.68 |
| 0.32 | TBPH | THERAVANCE BIOPHARMA INC | BMNDK09 | 9.85 | 18,741 | 184,598.85 |
| 0.31 | DNLI | DENALI THERAPEUTICS INC | BD2B4V0 | 20.92 | 8,742 | 182,882.64 |
| 0.31 | 853 HK | MICROPORT SCIENTIFIC CORP | B676TW7 | 0.84 | 216,302 | 182,684.91 |
| 0.31 | LTC | LTC PROPERTIES INC | 2498788 | 34.73 | 5,206 | 180,804.38 |
| 0.28 | ACAD | ACADIA PHARMACEU | 2713317 | 17.07 | 9,623 | 164,264.61 |
| 0.27 | 1789 HK | AK MEDICAL HOLDINGS LTD | BFD6SZ0 | 0.65 | 244,489 | 157,701.33 |
| 0.27 | AED BB | AEDIFICA | B1G5XP1 | 58.46 | 2,689 | 157,193.45 |
| 0.27 | RYM NZ | RYMAN HEALTHCARE LTD | 6161525 | 2.51 | 62,200 | 156,012.74 |
| 0.26 | AMED | AMEDISYS INC | 2024332 | 85.15 | 1,814 | 154,462.10 |
| 0.25 | LIVN | LIVANOVA PLC | BYMT0J1 | 46.75 | 3,096 | 144,738.00 |
| 0.24 | GN DC | GN STORE NORD A/S | 4501093 | 18.20 | 7,651 | 139,283.47 |
| 0.24 | 1302 HK | LIFETECH SCIENTIFIC CORP | BV9FKS0 | 0.19 | 734,692 | 138,100.89 |
| 0.22 | 2186 HK | LUYE PHARMA GROUP LTD | BNQ4GF3 | 0.28 | 465,424 | 129,431.75 |
| 0.22 | BKD | BROOKDALE SR | B0PZN33 | 5.07 | 25,134 | 127,429.38 |
| 0.21 | EKTAB SS | ELEKTA AB-B SHS | B0M42T2 | 5.44 | 22,913 | 124,635.31 |
| 0.19 | ATEC | ALPHATEC HOLDINGS INC | BD60BG7 | 9.23 | 11,947 | 110,270.81 |
| 0.13 | 145720 KS | DENTIUM CO LTD | BF07GJ6 | 42.77 | 1,774 | 75,880.67 |
| 0.10 | AGL | AGILON HEALTH INC | BLR4TK4 | 1.91 | 31,426 | 60,023.66 |
| 0.09 | OTHER PAYABLE & RECEIVABLES | 1.00 | 52,423 | 52,422.71 | ||
| 0.09 | ALEC | ALECTOR INC | BJ4LDC4 | 1.85 | 26,820 | 49,617.00 |
| 0.08 | 9229 JP | SUNWELS CO LTD | BNTYNB5 | 4.52 | 10,514 | 47,511.47 |
| 0.08 | 2500 HK | VENUS MEDTECH -H | BL6V047 | 0.43 | 102,940 | 44,689.97 |
| 0.00 | RADIUS HEALTH INC - CVR | 2KFF9T0 | 0.00 | 19,104 | 0.02 | |
| 0.00 | DANISH KRONE | 0.14 | -308 | -42.90 | ||
| 0.00 | EURO | 1.04 | -492 | -510.98 | ||
| -0.01 | CASH | 1.00 | -3,509 | -3,508.74 |
| Sector | Weight (%) | |
|---|---|---|
| Health Care | 91.4 | |
| Real Estate | 8.6 |
| Industry | Weight (%) | |
|---|---|---|
| Pharmaceuticals, Biotechnology & Life Sciences | 48.6 | |
| Health Care Equipment & Services | 41.7 | |
| Equity Real Estate Investment Trusts (REITs) | 8.9 | |
| Pharmaceuticals, Biotechnology | 0.8 |
| Country | Weight (%) | |
|---|---|---|
| United States | 53.9 | |
| Switzerland | 11.3 | |
| Japan | 8.1 | |
| Denmark | 4.5 | |
| Britain | 4.3 | |
| China | 4.1 | |
| Belgium | 3.5 | |
| Ireland | 2.9 | |
| South Korea | 2.6 | |
| Germany | 1.1 | |
| Australia | 1.1 | |
| Other | 2.6 |
All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.
Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.
AGNG traded under the ticker LNGR from inception until April 1, 2021.